Rick Winningham has held leadership positions in pharmaceutical companies. Rick served as the CEO of Theravance and as the President of Bristol-Myers Squibb's Oncology/Immunology/ Oncology Therapeutics Network (OTN) and Global Marketing divisions.
Rick Winningham attended Texas Christian University from 1982 to 1984, where they obtained their MBA degree in Quantitative Methods and Finance. Prior to that, they studied at Southern Illinois University@Carbondale from 1979 to 1981, earning their B.S. degree in Finance.
Sign up to view 18 direct reports
Get started